Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dianthus Therapeutics Inc.

DNTH
Current price
29.9 USD +0.19 USD (+0.64%)
Last closed 29.41 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 822 552 896 USD
Yield for 12 month +162.97 %
1Y
3Y
5Y
10Y
15Y
DNTH
21.11.2021 - 28.11.2021

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York. Address: 7 Times Square, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

50.1 USD

P/E ratio

Dividend Yield

Current Year

+2 826 000 USD

Last Year

+6 417 000 USD

Current Quarter

+1 863 000 USD

Last Quarter

+874 000 USD

Current Year

+2 471 000 USD

Last Year

+6 270 000 USD

Current Quarter

+1 752 000 USD

Last Quarter

+767 000 USD

Key Figures DNTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -68 679 000 USD
Operating Margin TTM -1191.84 %
PE Ratio
Return On Assets TTM -19.84 %
PEG Ratio
Return On Equity TTM -27.33 %
Wall Street Target Price 50.1 USD
Revenue TTM 4 118 000 USD
Book Value 12.2 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 92.3 %
Dividend Yield
Gross Profit TTM 6 417 000 USD
Earnings per share -1.93 USD
Diluted Eps TTM -1.93 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DNTH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DNTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:16
Payout Ratio
Last Split Date 12.09.2023
Dividend Date

Stock Valuation DNTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 112.2515
Price Sales TTM 199.7457
Enterprise Value EBITDA -7.3451
Price Book MRQ 2.2962

Financials DNTH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DNTH

For 52 weeks

6.58 USD 33.77 USD
50 Day MA 27.72 USD
Shares Short Prior Month 4 973 755
200 Day MA 25.7 USD
Short Ratio 16.99
Shares Short 4 727 188
Short Percent 22.66 %